Teva and Accord are the suppliers of Stanek tablets and Sastravi and the anticipated re-supply dates range between June and August 2020, DHSC has said (Photo: iStock).

The Department of Health and Social Care (DHSC) has issued a medicine supply notification for various strengths of Stanek and Sastravi (levodopa/carbidopa/entacapone) tablets.

Teva and Accord are the suppliers of Stanek tablets and Sastravi and the anticipated re-supply dates range between June and August 2020, DHSC has said.

Supplies of Stalevo tablets which are considered equivalent, continue to remain available.

A copy of this medicine supply notification has been sent to all pharmacy NHS email addresses.

DHSC has also issued a medicine supply notification for all formulations of Ranitidine.

Ranitidine 50mg/2ml injection is anticipated to be unavailable until further notice.

Ranitidine film-coated tablets, effervescent tablets and oral solution continue to remain out of stock.

All formulations of Ranitidine are affected due to on-going regulatory investigations into the presence of the contaminant, N-nitrosodimethylamine (NDMA), in samples of ranitidine active substance.

If you want to share your stories and/or experiences with us, please send an email to [email protected]

LEAVE A REPLY